ARCHIVES

Funding Opportunities.

This article is from The Cancer Letter archive.

Vol. 28 No. 19 | May 10, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

M.D. Anderson Wins 11th SPORE Grant.

July 3, 2008

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012